How to Justify Protocol Conditions Across Climatic Zones
Stability studies form the backbone of a pharmaceutical product’s shelf-life claim. Regulatory authorities across the world expect drug manufacturers to justify the storage conditions selected in the protocol, especially when products are registered in multiple climatic zones. The inability to justify protocol conditions can lead to rejection of stability data or delayed approvals. This guide…
Read More “How to Justify Protocol Conditions Across Climatic Zones” »
